Literature DB >> 10445062

Cytokines and adhesion molecules in middle ear cholesteatoma. A role in epithelial growth?

F Ottaviani1, C B Neglia, E Berti.   

Abstract

The immune response is thought to play a role in dysregulating epithelial growth in cholesteatoma of the middle ear. Through immunohistochemistry (using 18 monoclonal antibodies) on 10 specimens from human middle ear cholesteatomas, T-helper cells mixed with plasma cells, macrophages and scattered T-suppressor and B cells, have been detected in the perimatrix. Mast cells have also been identified in the perimatrix, usually close to the epithelium. Elements positive for D-related human leukocyte antigens (HLA-DR) were more than half of the immune cells. The endothelium of the perimatrix showed a sharp reactivity to the intercellular adhesion molecule-1 (ICAM1) and to the endothelial derived leukocyte adhesion molecule-1 (ELAM1), which play a role in recluting inflammatory cells and modulating the immune response. The expression of ICAM1 in the basal layer of the matrix indicates the homing of inflammatory reactions at the epithelial-stromal junction of the cholesteatoma. An intense expression of interferon-gamma receptor (IFN gamma R) was found in the basal layers of the cholesteatoma matrix, and overexpression of the epithelial growth factor receptor (EGFR) was found in all layers of the matrix. These data support the hypothesis that the epithelial cells in middle ear cholesteatoma are in an activated state and that their hyperproliferation is mediated through cytokines and adhesion molecules.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10445062     DOI: 10.1080/00016489950181008

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  7 in total

1.  EGFR expression in acquired middle ear cholesteatoma in children and adults.

Authors:  Adriana Leal Alves; Celina Siqueira Barbosa Pereira; Maria de Fatima Pereira Carvalho; Jose Humberto Tavares Guerreiro Fregnani; Fernando Quintanilha Ribeiro
Journal:  Eur J Pediatr       Date:  2011-07-29       Impact factor: 3.183

2.  Comparative analysis of the expression of E-cadherin, β-catenin, and β1 integrin in congenital and acquired cholesteatoma.

Authors:  Dong Wook Lee; Jae Ho Chung; Seung Hwan Lee; Chul Won Park; Sung-Ho Kang; Young Ha Oh; Ju Yeon Pyo
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-04-12       Impact factor: 2.503

Review 3.  Etiopathogenesis of cholesteatoma.

Authors:  Ewa Olszewska; Mathias Wagner; Manuel Bernal-Sprekelsen; Jörg Ebmeyer; Stefan Dazert; Henning Hildmann; Holger Sudhoff
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-06-27       Impact factor: 2.503

4.  The c-MYC protooncogene expression in cholesteatoma.

Authors:  Enikő Palkó; Szilárd Póliska; Zsuzsanna Csákányi; Gábor Katona; Tamás Karosi; Frigyes Helfferich; András Penyige; István Sziklai
Journal:  Biomed Res Int       Date:  2014-02-10       Impact factor: 3.411

Review 5.  Review of potential medical treatments for middle ear cholesteatoma.

Authors:  Matthias Schürmann; Peter Goon; Holger Sudhoff
Journal:  Cell Commun Signal       Date:  2022-09-19       Impact factor: 7.525

6.  The role of inflammatory mediators in the pathogenesis of otitis media and sequelae.

Authors:  Steven K Juhn; Min-Kyo Jung; Mark D Hoffman; Brian R Drew; Diego A Preciado; Nicholas J Sausen; Timothy T K Jung; Bo Hyung Kim; Sang-Yoo Park; Jizhen Lin; Frank G Ondrey; David R Mains; Tina Huang
Journal:  Clin Exp Otorhinolaryngol       Date:  2008-09-30       Impact factor: 3.372

7.  Analysis of histopathological aspects in acquired middle ear cholesteatoma.

Authors:  Adriana Leal Alves; Celina Siqueira Barbosa Pereira; Fernando de Andrade Quintanilha Ribeiro; Jose Humberto Tavares Guerreiro Fregnani
Journal:  Braz J Otorhinolaryngol       Date:  2008 Nov-Dec
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.